CCG
LLY icon

Chatham Capital Group’s Eli Lilly LLY Stock Holding History

Chatham Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Sell
9,058
-60
-0.7% -$61.3K 1.39% 17
2026
Q1 		$8.39M Sell
9,118
-49
-0.5% -$49.7K 1.22% 20
2025
Q4 		$9.85M Sell
9,167
-7
-0.1% -$6.69K 1.4% 18
2025
Q3 		$7M Sell
9,174
-330
-3% -$246K 1.01% 25
2025
Q2 		$7.41M Buy
9,504
+317
+3% +$246K 1.13% 24
2025
Q1 		$7.59M Sell
9,187
-237
-3% -$197K 1.27% 20
2024
Q4 		$7.28M Buy
9,424
+124
+1% +$103K 1.2% 21
2024
Q3 		$8.24M Buy
9,300
+236
+3% +$212K 1.35% 19
2024
Q2 		$8.21M Buy
9,064
+264
+3% +$211K 1.43% 15
2024
Q1 		$6.85M Buy
8,800
+752
+9% +$535K 1.26% 19
2023
Q4 		$4.69M Buy
8,048
+74
+0.9% +$43.2K 0.95% 32
2023
Q3 		$4.28M Buy
7,974
+424
+6% +$218K 0.96% 30
2023
Q2 		$3.54M Sell
7,550
-495
-6% -$208K 0.75% 43
2023
Q1 		$2.76M Buy
8,045
+1,165
+17% +$393K 0.62% 50
2022
Q4 		$2.52M Buy
6,880
+558
+9% +$198K 0.59% 58
2022
Q3 		$2.04M Buy
6,322
+277
+5% +$87.8K 0.5% 61
2022
Q2 		$1.96M Buy
6,045
+128
+2% +$38.4K 0.44% 65
2022
Q1 		$1.69M Buy
5,917
+1,330
+29% +$342K 0.33% 83
2021
Q4 		$1.27M Buy
4,587
+130
+3% +$33K 0.23% 101
2021
Q3 		$1.03M Buy
4,457
+217
+5% +$53.6K 0.2% 108
2021
Q2 		$973K Hold
4,240
– – 0.19% 115
2021
Q1 		$792K Sell
4,240
-200
-5% -$39.1K 0.17% 119
2020
Q4 		$750K Buy
4,440
+100
+2% +$14.9K 0.17% 115
2020
Q3 		$642K Sell
4,340
-200
-4% -$31K 0.16% 112
2020
Q2 		$745K Buy
4,540
+50
+1% +$7.67K 0.19% 106
2020
Q1 		$623K Hold
4,490
– – 0.18% 112
2019
Q4 		$590K Hold
4,490
– – 0.15% 117
2019
Q3 		$502K Hold
4,490
– – 0.13% 118
2019
Q2 		$497K Hold
4,490
– – 0.13% 122
2019
Q1 		$583K Sell
4,490
-65
-1% -$7.9K 0.15% 113
2018
Q4 		$527K Sell
4,555
-35
-0.8% -$3.91K 0.15% 111
2018
Q3 		$493K Hold
4,590
– – 0.12% 114
2018
Q2 		$392K Buy
4,590
+150
+3% +$12.3K 0.1% 117
2018
Q1 		$344K Sell
4,440
-100
-2% -$8.05K 0.09% 116
2017
Q4 		$383K Hold
4,540
– – 0.11% 113
2017
Q3 		$388K Hold
4,540
– – 0.11% 119
2017
Q2 		$374K Hold
4,540
– – 0.1% 123
2017
Q1 		$382K Hold
4,540
– – 0.11% 118
2016
Q4 		$334K Hold
4,540
– – 0.1% 118
2016
Q3 		$364K Hold
4,540
– – 0.11% 115
2016
Q2 		$358K Hold
4,540
– – 0.11% 113
2016
Q1 		$327K Sell
4,540
-100
-2% -$7.57K 0.1% 113
2015
Q4 		$391K Hold
4,640
– – 0.13% 108
2015
Q3 		$388K Hold
4,640
– – 0.13% 107
2015
Q2 		$387K Sell
4,640
-300
-6% -$22.9K 0.11% 122
2015
Q1 		$359K Hold
4,940
– – 0.11% 130
2014
Q4 		$341K Hold
4,940
– – 0.1% 134
2014
Q3 		$320K Buy
4,940
+640
+15% +$40.5K 0.1% 131
2014
Q2 		$267K Hold
4,300
– – 0.1% 96
2014
Q1 		$253K Hold
4,300
– – 0.1% 96
2013
Q4 		$219K Hold
4,300
– – 0.09% 108
2013
Q3 		$216K Sell
4,300
-200
-4% -$10.5K 0.1% 106
2013
Q2 		$221K Buy
+4,500
New +$245K 0.11% 109

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Chatham Capital Group's LLY Position: Q2 2026 in Review

Chatham Capital Group reduced its Eli Lilly (LLY) stake by 0.66% in Q2 2026, selling an estimated $61.3K and leaving 9,058 shares worth $10.9M. The position accounts for 1.39% of the portfolio, ranked #17.

Chatham Capital Group first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chatham Capital Group held 9,058 shares of Eli Lilly worth $10.9M as of Q2 2026.
  • Chatham Capital Group sold 60 Eli Lilly shares in Q2 2026, an estimated $61.3K.
  • Eli Lilly made up 1.39% of Chatham Capital Group's portfolio in Q2 2026, its #17 holding.
  • Chatham Capital Group first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.